Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-09

Clinical Trial Update: A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing LY900014 with insulin lispro (Humalog) in adults with type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)
  • LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2020-06-09